-
Postmarketing Safety Analysis of Nebivolol in Real-World Settings Using Bioinformatics and Disproportionality Analysis With FDA Adverse Event Reporting System (FAERS) Data
Sep 9, 2025, 16:22 PM -
The Enduring Economic Burden of COVID-19 and the Value of Vaccination Strategies in High-Income Countries
Sep 9, 2025, 16:22 PM -
Clinical Functional Profile and Neuroimaging in Cerebral Palsy: A Population-Based Study
Sep 9, 2025, 16:22 PM -
Alternative Pricing Policies for Multi-Indication Products: A Quantitative Analysis
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Targeted Therapy for Breast Cancer in Bulgaria
Sep 9, 2025, 16:22 PM -
Epidemiological Insights in Merkel Cell Carcinoma Across Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Understanding Treatment Preference Heterogeneity in Psoriasis: Insights From a Qualitative Analysis of Social Media Data
Sep 9, 2025, 16:22 PM -
Automated Excel-to-R Conversion of Health Economic Models Using the REEEVR Tool: Results of Alpha Test
Sep 9, 2025, 16:22 PM -
Impact of Companion Diagnostics (CDx) on Reimbursement Outcomes of Breast Cancer and NSCLC Therapies
Sep 9, 2025, 16:22 PM -
The SISAQOL-IMI Recommendations on Standardizing the Use of Thresholds for Interpretation of Patient-Reported Outcome Results in Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Economic Burden Utilities and Cost-Effectiveness of the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Descriptive Comparison of Patient Characteristics and Treatment Patterns in Metastatic NSCLC: US and France Cohorts to Inform Transportability
Sep 9, 2025, 16:22 PM -
Epidemiology and Institutional Treatment Distribution of Patients With Myelofibrosis (MF) in Germany: Insights From a Real-World Evidence Study
Sep 9, 2025, 16:22 PM -
Scoping the Future: Using NICE Scopes to Inform PICO Prediction for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Accelerating Therapeutic Innovation: Early Results From France’s Accès Direct Scheme
Sep 9, 2025, 16:22 PM -
Current Treatment Pathway for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in England: Insights From a Qualitative Validation With Clinical Experts
Sep 9, 2025, 16:22 PM -
Systems-Level Modeling Approaches for Complex Health Technologies: A Systematic Review
Sep 9, 2025, 16:22 PM -
France and the Challenge of High-Cost Innovative Drug Expenditures in Hospitals
Sep 9, 2025, 16:22 PM -
Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the Immune Thrombocytopenic Purpura Patient Assessment Questionnaire Item-10 (Physical Fatigue) and Idiopathic Thrombocytopenic Purpura Bleeding Scale Using LUNA 3 Phase 3 Trial Data
Sep 9, 2025, 16:22 PM
